Beobachtungsplan, NIS 622: IMPACT OF OCRELIZUMAB ON PATIENT REPORTED FATIGUE AND QUALITY OF LIFE IN RMS PATIENTS TREATED FOR THE FIRST TIME WITH OCRELIZUMAB (MOOZART): AN OBSERVATIONAL STUDY

Datei

• Artikel "Beobachtungsplan, NIS 622: IMPACT OF OCRELIZUMAB ON PATIENT REPORTED FATIGUE AND QUALITY OF LIFE IN RMS PATIENTS TREATED FOR THE FIRST TIME WITH OCRELIZUMAB (MOOZART): AN OBSERVATIONAL STUDY"Herunterladen(PDF, 2MB, Datei ist nicht barrierefrei)